Efficacy of Amantadine Treatment in COVID-19 Patients
Status:
Recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
Demonstration of the efficacy of amantadine over placebo in the population of patients with
moderate or severe COVID-19 in the initial stage of the disease treated in the hospital
Phase:
Phase 3
Details
Lead Sponsor:
Noblewell
Collaborators:
Leszek Giec Upper-Silesian Medical Centre of the Silesian Medical University in Katowice Medical Research Agency (ABM)